CVS Pharmacy to pay $1.5M for violations of the Controlled Substances Act

CVS PHARMACY has agreed to pay $1.5 million for violations of the Controlled Substances Act in New York to resolve a federal investigation. Stores on Long Island had failed to report loss or stolen controlled substances in a timely manner. / BLOOMBERG FILE PHOTO/CHRISTOPHER LEE
CVS PHARMACY has agreed to pay $1.5 million for violations of the Controlled Substances Act in New York to resolve a federal investigation. Stores on Long Island had failed to report lost or stolen controlled substances in a timely manner. / BLOOMBERG FILE PHOTO/CHRISTOPHER LEE

WOONSOCKET – CVS Pharmacy Inc., the subsidiary of CVS Health Corp., has agreed to pay $1.5 million to resolve a federal investigation into certain stores on Long Island, N.Y., that failed to report the loss or theft of controlled substances, including the opioid hydrocodone, the U.S. Department of Justice announced Thursday.

“The failure to promptly report the loss or theft of prescription drugs as required by law contributes to the opioid epidemic, which has caused devastating harm to individuals and our community,” said Richard P. Donoghue, United States Attorney for the Eastern District of New York, in a statement. “The settlement with CVS demonstrates the resolve by this office and the [Drug Enforcement Administration, New York Division] to use all available tools to address this crisis at every level and reduce the availability of highly addictive, dangerous drugs.”

Understanding Robotic-Assisted Surgery: Insights from the Experts

Advances in robotics are transforming our world, and healthcare is no exception. Robotic-assisted surgery is…

Learn More

The settlement was announced by the U.S. Attorney’s Office, Eastern District of New York.

CVS Pharmacy did not respond for comment by the time of publication.

- Advertisement -

No posts to display